首页> 外国专利> DRUG DELIVERY COMPOSITION OF OCULAR INSERT USING POLYMETHYLMETHACRYLATE AND POLYETHYLENE OXIDE FOR ANTI-GLAUCOMA DRUGS

DRUG DELIVERY COMPOSITION OF OCULAR INSERT USING POLYMETHYLMETHACRYLATE AND POLYETHYLENE OXIDE FOR ANTI-GLAUCOMA DRUGS

机译:聚甲基丙烯酸甲酯和聚环氧乙烷用于抗青光眼药物的眼用药物药物输送组合物

摘要

The present inventions provide Drug Delivery Composition of Ocular Insert Using Polymethylmethacrylate (PMMA) and Polyethylene Oxide (PEO) for Anti-Glaucoma Drugs with a view to improve its therapeutic efficacy by producing sustained action of the drug and reducing its side effects. The blend of PEO in PMMA matrix was found to be homogenous in nature. It was found that drugs permeation was decreased with increasing polymer concentration. It was also concluded that presence of PEO in films favors the drugs release and so permeation whereas PMMA retards drugs release. Isopropyl Alcohol use in formulation of ocular insert was play a major role in improving its corneal penetration and hence increase it therapeutic effectiveness of the drugs.
机译:本发明提供用于抗青光眼药物的使用聚甲基丙烯酸甲酯(PMMA)和聚环氧乙烷(PEO)的眼用插入物的药物递送组合物,以通过产生药物的持续作用并减少其副作用来改善其治疗功效。发现PEO在PMMA基质中的混合物本质上是均匀的。发现随着聚合物浓度的增加,药物渗透降低。还得出结论,薄膜中PEO的存在有利于药物释放和渗透,而PMMA则抑制药物释放。异丙醇在眼用插入剂配方中的使用在改善其角膜渗透性并因此提高其药物治疗效果方面起着重要作用。

著录项

  • 公开/公告号IN201721014685A

    专利类型

  • 公开/公告日2017-05-19

    原文格式PDF

  • 申请/专利权人

    申请/专利号IN201721014685

  • 发明设计人 RAJESH MUJORIYA;

    申请日2017-04-25

  • 分类号A61K31/573;A61K31/56;

  • 国家 IN

  • 入库时间 2022-08-21 13:38:21

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号